NO20091016L - Pyridooksazepin-progesteron reseptormodulatorer - Google Patents
Pyridooksazepin-progesteron reseptormodulatorerInfo
- Publication number
- NO20091016L NO20091016L NO20091016A NO20091016A NO20091016L NO 20091016 L NO20091016 L NO 20091016L NO 20091016 A NO20091016 A NO 20091016A NO 20091016 A NO20091016 A NO 20091016A NO 20091016 L NO20091016 L NO 20091016L
- Authority
- NO
- Norway
- Prior art keywords
- receptor modulators
- progesterone receptor
- pyridooksazepine
- fluorodibenzo
- oxazepine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Gynecology & Obstetrics (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06121372 | 2006-09-27 | ||
PCT/EP2007/060225 WO2008037746A1 (fr) | 2006-09-27 | 2007-09-26 | Modulateurs des récepteurs de la progestérone de type pyridooxazépine |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20091016L true NO20091016L (no) | 2009-03-30 |
Family
ID=37813577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20091016A NO20091016L (no) | 2006-09-27 | 2009-03-06 | Pyridooksazepin-progesteron reseptormodulatorer |
Country Status (28)
Country | Link |
---|---|
EP (1) | EP2066677B1 (fr) |
JP (1) | JP2010504943A (fr) |
KR (1) | KR20090064454A (fr) |
CN (1) | CN101522689B (fr) |
AR (1) | AR063018A1 (fr) |
AT (1) | ATE478078T1 (fr) |
AU (1) | AU2007302007B2 (fr) |
BR (1) | BRPI0716830A2 (fr) |
CA (1) | CA2664120A1 (fr) |
CL (1) | CL2007002788A1 (fr) |
CO (1) | CO6160325A2 (fr) |
CY (1) | CY1110846T1 (fr) |
DE (1) | DE602007008589D1 (fr) |
DK (1) | DK2066677T3 (fr) |
ES (1) | ES2349325T3 (fr) |
HK (1) | HK1126767A1 (fr) |
HR (1) | HRP20100526T1 (fr) |
IL (1) | IL197365A0 (fr) |
MX (1) | MX2009002804A (fr) |
NO (1) | NO20091016L (fr) |
NZ (1) | NZ575276A (fr) |
PE (1) | PE20071451A1 (fr) |
PL (1) | PL2066677T3 (fr) |
PT (1) | PT2066677E (fr) |
RU (1) | RU2009115643A (fr) |
SI (1) | SI2066677T1 (fr) |
TW (1) | TW200820975A (fr) |
WO (1) | WO2008037746A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI297685B (en) | 2002-04-04 | 2008-06-11 | Organon Nv | Non-steroidal progesterone receptor modulators |
CN101200429B (zh) * | 2006-12-13 | 2012-08-22 | 上海睿智化学研究有限公司 | 2-硝基-4,5-二卤代苯酚类和2-氨基-4,5-二卤代苯酚类及其盐及其合成方法 |
US8063037B2 (en) | 2007-05-07 | 2011-11-22 | N. V. Organon | Progesterone receptor modulators |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1317456A2 (fr) * | 2000-09-07 | 2003-06-11 | Bayer Corporation | Amidines cycliques et acycliques et compositions pharmaceutiques contenant ces composes utilises comme agents de liaison de recepteur de progesterone |
TWI297685B (en) * | 2002-04-04 | 2008-06-11 | Organon Nv | Non-steroidal progesterone receptor modulators |
-
2007
- 2007-09-26 DE DE602007008589T patent/DE602007008589D1/de active Active
- 2007-09-26 CA CA002664120A patent/CA2664120A1/fr not_active Abandoned
- 2007-09-26 AT AT07820620T patent/ATE478078T1/de active
- 2007-09-26 AU AU2007302007A patent/AU2007302007B2/en not_active Ceased
- 2007-09-26 WO PCT/EP2007/060225 patent/WO2008037746A1/fr active Application Filing
- 2007-09-26 EP EP07820620A patent/EP2066677B1/fr active Active
- 2007-09-26 BR BRPI0716830-6A patent/BRPI0716830A2/pt not_active IP Right Cessation
- 2007-09-26 PL PL07820620T patent/PL2066677T3/pl unknown
- 2007-09-26 CN CN2007800361667A patent/CN101522689B/zh not_active Expired - Fee Related
- 2007-09-26 SI SI200730404T patent/SI2066677T1/sl unknown
- 2007-09-26 ES ES07820620T patent/ES2349325T3/es active Active
- 2007-09-26 DK DK07820620.8T patent/DK2066677T3/da active
- 2007-09-26 KR KR1020097007645A patent/KR20090064454A/ko not_active Application Discontinuation
- 2007-09-26 JP JP2009529699A patent/JP2010504943A/ja not_active Ceased
- 2007-09-26 NZ NZ575276A patent/NZ575276A/en unknown
- 2007-09-26 MX MX2009002804A patent/MX2009002804A/es not_active Application Discontinuation
- 2007-09-26 RU RU2009115643/04A patent/RU2009115643A/ru not_active Application Discontinuation
- 2007-09-26 TW TW096135743A patent/TW200820975A/zh unknown
- 2007-09-26 PT PT07820620T patent/PT2066677E/pt unknown
- 2007-09-27 PE PE2007001315A patent/PE20071451A1/es not_active Application Discontinuation
- 2007-09-27 CL CL200702788A patent/CL2007002788A1/es unknown
- 2007-09-27 AR ARP070104267A patent/AR063018A1/es not_active Application Discontinuation
-
2009
- 2009-03-03 IL IL197365A patent/IL197365A0/en unknown
- 2009-03-06 NO NO20091016A patent/NO20091016L/no not_active Application Discontinuation
- 2009-03-27 CO CO09031994A patent/CO6160325A2/es unknown
- 2009-06-24 HK HK09105660.9A patent/HK1126767A1/xx not_active IP Right Cessation
-
2010
- 2010-09-24 HR HR20100526T patent/HRP20100526T1/hr unknown
- 2010-10-21 CY CY20101100942T patent/CY1110846T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP2066677B1 (fr) | 2010-08-18 |
CN101522689B (zh) | 2012-01-11 |
CL2007002788A1 (es) | 2008-04-18 |
KR20090064454A (ko) | 2009-06-18 |
JP2010504943A (ja) | 2010-02-18 |
DE602007008589D1 (de) | 2010-09-30 |
WO2008037746A1 (fr) | 2008-04-03 |
HRP20100526T1 (hr) | 2010-11-30 |
PT2066677E (pt) | 2010-11-10 |
CO6160325A2 (es) | 2010-05-20 |
DK2066677T3 (da) | 2010-11-08 |
NZ575276A (en) | 2011-07-29 |
CA2664120A1 (fr) | 2008-04-03 |
TW200820975A (en) | 2008-05-16 |
BRPI0716830A2 (pt) | 2013-11-05 |
ATE478078T1 (de) | 2010-09-15 |
PE20071451A1 (es) | 2008-10-30 |
CN101522689A (zh) | 2009-09-02 |
EP2066677A1 (fr) | 2009-06-10 |
SI2066677T1 (sl) | 2010-12-31 |
IL197365A0 (en) | 2009-12-24 |
ES2349325T3 (es) | 2010-12-30 |
HK1126767A1 (en) | 2009-09-11 |
AR063018A1 (es) | 2008-12-23 |
CY1110846T1 (el) | 2015-06-10 |
AU2007302007B2 (en) | 2012-02-02 |
MX2009002804A (es) | 2009-03-31 |
RU2009115643A (ru) | 2010-11-10 |
PL2066677T3 (pl) | 2011-02-28 |
AU2007302007A1 (en) | 2008-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE526318T1 (de) | Farnesoid-x-rezeptor-agonisten | |
ATE473744T1 (de) | Modifizierte pyrimidin-glucocorticoid-rezeptor- modulatoren | |
EA200900781A1 (ru) | 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды | |
NO20075298L (no) | Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists | |
DK1833799T3 (da) | 3-phenyl-pyrazol derivater, som modulatorer af 5-HT-2a-serotonin receptor nyttig til behandlingen af sygdomme relateret hertil | |
EA200801758A1 (ru) | Лекарственные формы, устойчивые к самовольному изменению | |
NO20093146L (no) | Amino-pyridinderivater som S1P1/EDG1-reseptoragonister | |
WO2009012275A9 (fr) | Agonistes du récepteur gpr119 couplé à la protéine g pyridone | |
MX2010004374A (es) | Armazones proteinicos. | |
DK3093291T3 (da) | Disubstituerede octahy-dropyrrolo [3,4-c]pyrroler som orexinreceptormodulatorer | |
DK1928845T3 (da) | Aminodiazepiner som toll-lignende receptor-modulatorer | |
NO20091395L (no) | Nye tiofenderivater | |
DK1984345T3 (da) | Benzoxaziner og beslægtede nitrogenholdige heterobicykliske forbindelser, der kan anvendes som mineralcorticoidreceptormodulerende midler | |
EA200800713A1 (ru) | Аморфные твёрдые дисперсии | |
MX2010002028A (es) | Metodos y composiciones para modular celulas t. | |
CO6241120A2 (es) | (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS. | |
UA104438C2 (uk) | Спосіб одержання дабігатрану і його проміжних сполук | |
NO20070379L (no) | Kjemiske forbindelser | |
EA201000258A1 (ru) | Новые гербициды | |
DK2238110T3 (da) | 5.6-bisaryl-2-pyridin-carboxamid-derivater, fremstilling heraf og terapeutisk anvendelse heraf som urotensin II-receptorantagonister | |
NO20083593L (no) | Anti-EphrinB2-antistoffer og fremgangsmater for anvendelse av disse | |
DK2094684T3 (da) | 1,5-diphenyl-3-benzylamino-1,5-dihydropyrrolidin-2-on som CB1-receptor modulatorer | |
NO344044B1 (no) | Nye triazindionderivater som GABA-B-reseptormodulatorer | |
MX2009010288A (es) | Dispositivo para la administracion de composiciones viscosas. | |
MX2008000874A (es) | Metodos y composiciones para anticoncepcion de emergencia utilizando antagonistas del receptor de endotelina. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |